BTD and cancer: As shown in Table 1, a blinded set of plasmas from 21 breast cancer patients (age = 36 - 78, cancer grade = O - IV) and 21 normal healthy women (age = 17 - 49) were tested to determine individual levels of BTD and GPX3 by Western blots.